医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

New Promega Reagent and Software Tool Monitors Performance of Mass Spectrometry and Liquid Chromatography Instruments

2015年02月12日 PM11:00
このエントリーをはてなブックマークに追加


 

MADISON, Wis.

Promega Corporation announces the release of the 6 × 5 LC-MS/MS Peptide Reference Mix, a novel reagent and software combination. The reagent monitors LC and MS parameters, while the complementary software reports on instrument performance, as well as performance history.

New Promega 6 x 5 LC-MS/MS Peptide Reference Mix evaluates both liquid chromatography (LC) columns a ...

New Promega 6 x 5 LC-MS/MS Peptide Reference Mix evaluates both liquid chromatography (LC) columns and mass spectrometry (MS) instruments. (Photo: Business Wire)

The unique peptide formulation saves time by assessing multiple LC and MS parameters, such as peak height, mass accuracy, dynamic range and sensitivity, in a single run. The AAA-qualified peptides result in accurate reporting of instrument sensitivity and dynamic range. The 6 × 5 LC-MS/MS Peptide Reference Mix can be used in multiple applications, with either neat or complex sample mixtures. The complementary PReMiS™ Software tool eliminates time-consuming manual calculations, and monitors instrument-to-instrument performance over time.

“With the 6 × 5 LC-MS/MS Peptide Reference Mix, you can check the stability of your LC, the sensitivity and dynamic range of your MS, and monitor instrument performance in every run. And in a matter of minutes, the free software tool reports the results,” said Gary Kobs, Senior Global Product Manager at Promega Corporation.

Hardware required to run the PReMiS™ Software includes a Windows® PC with a Dual-Core x86 based processor, 4GB Memory, 100GB hard drive, video 1024 × 768 pixels, and Microsoft Windows® XP® SP3, Vista® 32/64, Windows® 7 32/64, or Windows® 8 32/64.

For more information visit: www.promega.com/6x5prlc_ms

Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s 3,000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, drug discovery and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 16 countries and over 50 global distributors. For more information about Promega, visit www.promega.com.

Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20150212005036/en/

CONTACT

Promega Corporation
Penny Patterson
Sr. Director,
Communications
(608) 274-4330
penny.patterson@promega.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Chi-Med Initiates Fruquintinib U.S. Clinical Trials
  • Orthocell Granted European Tendon Regeneration Patent
  • Clover Biopharmaceuticals Completes RMB 62.8 Million Series A Financing
  • 三叶草生物制药完成6,280万元人民币A轮融资
  • Corindus Announces First Commercial Installation of CorPath® GRX System Outside of U.S.